Franco Maggiolo

Whole-genome sequencing reveals host factors underlying critical COVID-19

Athanasios Kousathanas, Erola Pairo‐Castineira, Konrad Rawlik et al. · Nature · 2022 · 347 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

Similar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Nonnucleoside Analogues or Protease Inhibitors

Franco Maggiolo, Laura Ravasio, D Ripamonti et al. · Clinical Infectious Diseases · 2004 · 222 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

Franco Maggiolo · Patient Preference and Adherence · 2010 · 182 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial

Josep M. Llibre, Carlos Brites, Chien‐Yu Cheng et al. · Clinical Infectious Diseases · 2022 · 170 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15

Effect of Adherence to HAART on Virologic Outcome and on the Selection of Resistance-Conferring Mutations in NNRTI- or PI-Treated Patients

Franco Maggiolo, Monica Airoldi, Annapaola Callegaro et al. · HIV Clinical Trials · 2007 · 162 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17